COMPANY

Cellecta, Incorporated

HQ: Mountain View, CA source · cellecta.com ↗ · West Coast

Keywords: next-generation sequencing NGS

Location: Mountain View, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

25NIH grants

NIH awards 25

Annual award amounts. Total $11.8M.

Dec 1, 2017 NIH award 5R44HG008578-03 FY2018: $844,431 awarded for that fiscal year; activity R44 (SBIR); PI TEDESCO, DONATO; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. CRISPR Genome-Wide sgRNA Library Screening Pl source ↗
Dec 16, 2016 NIH award 2R44HG008578-02 FY2017: $651,831 awarded for that fiscal year; activity R44 (SBIR); PI TEDESCO, DONATO; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. CRISPR Genome-Wide sgRNA Library Screening Pl source ↗
May 15, 2015 NIH award 1R43HG008578-01 FY2015: $224,905 awarded for that fiscal year; activity R43 (SBIR); PI TEDESCO, DONATO; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Open Resource CRISPR/CAS9 Genome-Wide sgRNA L source ↗
2013 NIH contract (government contract; not a grant and not an investment round) 261201300032C-0-0-1 FY2013: $299,952 awarded for that fiscal year; activity N43 (OTHER_NIH); PI CHENCHIK, ALEXANDER; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. IGF::OT::I source ↗
Aug 29, 2012 NIH award 5R44CA141848-03 FY2012: $905,570 awarded for that fiscal year; activity R44 (SBIR); PI BONNEAU, KYLE RUSSELL; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Exploiting synthetic lethality of hemat source ↗
2012 NIH contract (government contract; not a grant and not an investment round) 261201200065C-0-0-1 FY2012: $999,596 awarded for that fiscal year; activity N44 (OTHER_NIH); PI CHENCHIK, ALEXANDR; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. OTHER FUNCT source ↗
Aug 23, 2011 NIH award 2R44CA141848-02 FY2011: $941,894 awarded for that fiscal year; activity R44 (SBIR); PI BONNEAU, KYLE RUSSELL; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Exploiting synthetic lethality of hemat source ↗
Jul 29, 2011 NIH award 5R44RR024095-03 FY2011: $1,021,240 awarded for that fiscal year; activity R44 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Functionally Validated Lentiviral siRNA libr source ↗
Jun 3, 2011 NIH award 5R43CA144511-02 FY2011: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI KOMAROV, ANDREY; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Isolation of Peptide Radioprotectors source ↗
Sep 3, 2010 NIH award 2R44RR024095-02 FY2010: $839,064 awarded for that fiscal year; activity R44 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Functionally Validated Lentiviral siRNA librar source ↗
May 27, 2010 NIH award 1R43CA144511-01 FY2010: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI KOMAROV, ANDREY; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Isolation of Peptide Radioprotectors source ↗
2010 NIH contract (government contract; not a grant and not an investment round) 261201000078C-0-0-1 FY2010: $199,681 awarded for that fiscal year; activity N43 (OTHER_NIH); PI CHENCHIK, ALEXANDR; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. TAS::75 084 source ↗
Aug 13, 2009 NIH award 5R43CA132841-02 FY2009: $94,729 awarded for that fiscal year; activity R43 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Array-assisted Insertional Mutagenesis Platform source ↗
Jul 21, 2009 NIH award 5R43CA134062-02 FY2009: $151,643 awarded for that fiscal year; activity R43 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Viability Pathway Models in Prostate Cancer Ce source ↗
Jul 8, 2009 NIH award 5R44HG003355-04 FY2009: $934,752 awarded for that fiscal year; activity R44 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Algorithm and genome-wide database of function source ↗
Jun 19, 2009 NIH award 1R43CA141883-01 FY2009: $234,168 awarded for that fiscal year; activity R43 (SBIR); PI KOMAROV, ANDREY; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Inhibitors of Heat Shock Response source ↗
Jun 19, 2009 NIH award 1R43CA141855-01 FY2009: $237,368 awarded for that fiscal year; activity R43 (SBIR); PI KOMAROV, ANDREY; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Drug Targets of Heat Shock Response source ↗
Jun 19, 2009 NIH award 1R43CA141848-01 FY2009: $249,465 awarded for that fiscal year; activity R43 (SBIR); PI BONNEAU, KYLE RUSSELL; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Identification of Hematopoietic Stem an source ↗
Sep 25, 2008 NIH award 1R43CA132841-01 FY2008: $92,940 awarded for that fiscal year; activity R43 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Array-assisted Insertional Mutagenesis Platform source ↗
Sep 16, 2008 NIH award 3R44HG003355-03S1 FY2008: $160,500 awarded for that fiscal year; activity R44 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Algorithm and genome-wide database of functi source ↗
Aug 11, 2008 NIH award 5R44HG003355-03 FY2008: $741,109 awarded for that fiscal year; activity R44 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Algorithm and genome-wide database of function source ↗
Aug 7, 2008 NIH award 1R43CA134062-01 FY2008: $146,430 awarded for that fiscal year; activity R43 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Viability Pathway Models in Prostate Cancer Ce source ↗
Sep 23, 2007 NIH award 2R44HG003355-02 FY2007: $703,750 awarded for that fiscal year; activity R44 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Algorithm and genome-wide database of function source ↗
Jul 5, 2007 NIH award 1R43RR024095-01 FY2007: $289,398 awarded for that fiscal year; activity R43 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. Functionally Validated Lentiviral siRNA Librar source ↗
Jun 27, 2007 NIH award 1R43RR024323-01 FY2007: $252,345 awarded for that fiscal year; activity R43 (SBIR); PI CHENCHIK, ALEX; recipient as written: CELLECTA, INC., MOUNTAIN VIEW, CA. High Throughput Screening of Peptide Pharmaceu source ↗